Lester Hockenberry
Internal Medicine · Harvey, ILNPI 1538114715
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 143 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 23 manufacturers reported payments, led by Lilly USA, LLC at 42.0% of the total.
Across 143 payments — averaging $18.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$1K
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$228
- Pfizer$157
- Merck$151
- AstraZeneca$147
- GSK$120
- plus $697 from 17 others
What the payments were for
- Food & beverage$2,587100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 64 | $1,087 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 5 | $228 |
| Pfizer | 13 | $157 |
| Merck | 8 | $151 |
| AstraZeneca | 10 | $147 |
| GSK | 6 | $120 |
| Exact Sciences | 5 | $108 |
| Gilead | 4 | $99 |
| Novartis | 5 | $95 |
| Novo Nordisk | 4 | $79 |
| Boehringer Ingelheim | 3 | $64 |
| Bayer | 2 | $40 |
| Arbor Pharmaceuticals, Inc. | 3 | $39 |
| Amgen | 2 | $30 |
| AbbVie | 1 | $19 |
| E.r. Squibb & Sons, L.L.C. | 1 | $18 |
| Sanofi Pasteur Inc. | 1 | $17 |
| Sumitomo Pharma America, Inc. | 1 | $17 |
| Kowa Pharmaceuticals America, Inc. | 1 | $16 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $15 |
| Cranial Technologies, Inc | 1 | $14 |
| Sanofi-aventis U.S. LLC | 1 | $14 |
| Sobi, Inc | 1 | $13 |
How this compares
$2,587 in reported general payments places this provider in the 85th percentile of 5,182 internal medicine providers in Illinois.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 131 | $174,550 |
| TrulicityDulaglutide | 44 | $63,782 |
| EliquisApixaban | 22 | $31,810 |
| OzempicSemaglutide | 32 | $29,356 |
| MounjaroTirzepatide | 18 | $25,810 |
| EntrestoSacubitril/Valsartan | 17 | $24,885 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 19 | $13,085 |
| XareltoRivaroxaban | 14 | $12,070 |
| Fiasp FlextouchInsulin Aspart (Niacinamide) | 15 | $11,099 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 65 | $9,073 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 13 | $8,937 |
| MyrbetriqMirabegron | 14 | $8,102 |
| SymbicortBudesonide/Formoterol Fumarate | 29 | $7,048 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 13 | $4,040 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 131 | $3,933 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance, Stiolto Respimat | $64 | $183,487144 claims |
| Lilly USA, LLCTrulicity, Mounjaro | $1,087 | $89,59262 claims |
| PfizerEliquis | $157 | $31,81022 claims |
| Novo NordiskOzempic | $79 | $29,35632 claims |
| NovartisEntresto | $95 | $24,88517 claims |
| GSKTrelegy Ellipta | $120 | $13,08519 claims |
| AstraZenecaSymbicort | $147 | $7,04829 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 5,182 internal medicine providers in Illinois.
Other internal medicine in Harvey
- Zaid JabbarOak Brook$1.2M
- Merle DiamondChicago$1.1M
- David ReckerLibertyville$868K
- Yazen JoudehOrland Park$661K
- Robert KushnerChicago$516K
- William CruikshankOak Lawn$431K
- Romeo UrsuaChicago$420K
- Shaina RozellChicago Ridge$366K
- Kristi Tough DesapriWinnetka$344K
- Peter O DonnellChicago$318K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.